INDUSTRI DAN PERDAGANGAN BINTRACO DHARMA (CARS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Revenue for the nine months ended September 30, 2024 reached Rp4.56 trillion, a slight decrease from Rp4.60 trillion in the same period last year.
Net profit attributable to owners was Rp136.88 billion, down from Rp143.81 billion year-over-year.
Total assets as of September 30, 2024 stood at Rp3.63 trillion, a decrease from Rp3.87 trillion at year-end 2023.
The group continues to face capital deficiencies and going concern issues in several subsidiaries.
Financial highlights
Gross profit for the nine months was Rp562.18 billion, slightly down from Rp565.52 billion year-over-year.
Operating profit reached Rp247.02 billion, a decrease from Rp272.65 billion in the prior year.
Net comprehensive income for the period was Rp148.74 billion, compared to Rp155.43 billion last year.
Basic earnings per share for the period was Rp9.13, down from Rp9.59 year-over-year.
Cash and cash equivalents at period end were Rp422.15 billion, down from Rp464.48 billion at year-end 2023.
Segment performance
Automotive segment contributed Rp4.50 trillion in revenue, with aftersales at Rp56.81 billion and consumer financing at Rp4.38 million.
Automotive gross profit was Rp551.89 billion, aftersales gross profit was Rp15.86 billion.
Financing segment reported a net loss before tax of Rp13.63 billion.
Latest events from INDUSTRI DAN PERDAGANGAN BINTRACO DHARMA
- Revenue and profit declined, with ongoing restructuring amid subsidiary capital risks.CARS
Q3 20252 Nov 2025 - Revenue and net profit fell in H1 2025, with ongoing restructuring and improved leverage.CARS
Q2 20251 Sep 2025 - Revenue up, net income steady, but capital deficiencies persist in key subsidiaries.CARS
Q2 202413 Jun 2025 - Net profit and revenue declined, with multiple subsidiaries facing going concern risks.CARS
Q1 20256 Jun 2025 - Net income rose to Rp210.4 billion, but going concern risks persist in key subsidiaries.CARS
Q4 20246 Jun 2025